UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000035121
Receipt No. R000039806
Scientific Title Efficacy and Safety of Ruxolitinib single treatment in patients with chronic active Epstein-Barr virus infection (Phase II) (investigator-initiated study)
Date of disclosure of the study information 2018/12/15
Last modified on 2019/06/13 15:30:11

No. Disposal Last modified on Item of update
1 Insert 2018/12/03 17:55:51
2 Update 2018/12/25 16:04:15 Anticipated trial start date
3 Update 2019/01/09 11:26:34 Recruitment status
Anticipated trial start date
4 Update 2019/02/08 16:28:30 Institutions
5 Update 2019/04/16 14:08:56 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL

Last name of contact person

Last name of contact person
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Name of primary sponsor
Institute
Organization
Organization
Address
Address
Tel
Email
6 Update 2019/04/16 14:15:52 Date of IRB
Last follow-up date
7 Update 2019/04/16 14:20:24 Key inclusion criteria
Key inclusion criteria
8 Update 2019/04/16 15:26:35 UMIN ID2
9 Update 2019/04/16 15:56:02 Division name
10 Update 2019/06/13 13:26:35 UMIN ID1
11 Update 2019/06/13 15:30:11 Organization1
Address1
Tel1
Email1
Organization
Organization
Address
Address
Tel
Email


Contact us.